Results 281 to 290 of about 411,291 (407)

Metaanálisis en cirugía cardiovascular: una herramienta estadística muy valiosa

Cirugía Cardiovascular
Stefano Urso, Victor Dayan
doaj  

Patient Management Following Percutaneous Coronary Intervention. [PDF]

JACC Adv
Wennberg E, Abualsaud AO, Eisenberg MJ.
europepmc   +1 more source

Staged versus non staged approach for multivessel percutaneous coronary interventions Andrea S. Abizaid, Roxana Mehran, Alexandre Abizaid, George Dangas, Luis Gruberg, Augusto D. Pichard, Ron Waksman, Lowell F. Satler, Kenneth M. Kent, Alexandra J. Lansky, Gregg W. Stone, Martin B. Leon. Cardiovascular Research Foundation, New York, NY, Washington Hospital Center, Washington, DC

, 2001

openalex   +1 more source

Improved and Automated Detection of Papillary Muscle Infarction Using Joint Bright‐ and Black‐Blood Late Gadolinium Enhancement MRI

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Papillary muscle infarction (PMI) has been linked to significantly increased mortality and is associated with ventricular arrhythmias and mitral regurgitation. Reference bright‐blood late gadolinium enhancement (LGE) imaging provides poor scar‐to‐blood contrast, making PMI visualization challenging. Black‐blood LGE imaging overcomes
Théo Richard, Victor de Villedon de Naide, Victor Nogues, Thaïs Génisson, Kalvin Narceau, Kun He, Rabea Klaar, Baptiste Durand, Thibault Boullé, Guillaume Poirot, Soumaya Sridi, Jean‐David Maes, Marion Constantin, Kinan Kneizeh, Konstantinos Vlachos, Guido Caluori, Pierre Jaïs, Matthias Stuber, Hubert Cochet, Aurelien Bustin   +19 more
wiley   +1 more source

Towards a dynamic model to estimate evolving risk of major bleeding after percutaneous coronary intervention. [PDF]

PLOS Digit Health
Hurley NC, Desai N, Dhruva SS, Khera R, Schulz W, Huang C, Curtis J, Masoudi F, Rumsfeld J, Negahban S, Krumholz HM, Mortazavi BJ.   +11 more
europepmc   +1 more source

Myocardial stress perfusion imaging 1 day after percutaneous coronary intervention in the modern era Sherif S. Iskander, John J. Mahmarian, Neil S. Kleiman, Albert E. Raizner, Mario S. Verani. Baylor College of Medicine/The Methodist Hospital, Houston, TX

, 2001

openalex   +1 more source

Optimising Radiation Dose Estimation: UNSCEAR DAP‐to‐ED Conversion in Uterine Artery Embolisation

Journal of Medical Radiation Sciences, EarlyView.
This study uses the conversion factors from the ‘UNSCEAR Global Survey on Medical Exposure: A User Manual’ to estimate radiation dose exposure for patients undergoing uterine artery embolisation. Estimating the effective dose provides interventional radiologists and interventional radiographers a better understanding of the stochastic risks associated ...
Don J. Nocum, John Robinson, Warren Reed
wiley   +1 more source

Immediate protamine administration and sheath removal following percutaneous coronary intervention John Ducas, Michael C. Y. Chan, Anthony Miller, Tarek Kashour. University of Manitoba, Winnipeg, MB, Canada

, 2001

openalex   +1 more source

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

The Lancet, 2018
S. Head, M. Milojevic, J. Daemen, Jung‐Min Ahn, E. Boersma, E. H. Christiansen, M. Domanski, M. Farkouh, M. Flather, V. Fuster, M. Hlatky, N. Holm, W. Hueb, M. Kamalesh, Young-Hak Kim, T. Mäkikallio, F. Mohr, G. Papageorgiou, Seung‐Jung Park, Alfredo E. Rodríguez, J. Sabik, R. Stables, G. Stone, P. Serruys, A. Kappetein   +24 more
semanticscholar   +1 more source

Hypoxia‐Enhanced Wharton's Jelly Mesenchymal Stem Cell Therapy for Liver Fibrosis: A Comparative Study in a Rat Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Liver fibrosis is a progressive disease that can lead to cirrhosis and liver failure, with limited treatment options. Wharton's jelly‐derived MSCs (WJ‐MSCs) have immunomodulatory and antifibrotic potential. Hypoxia preconditioning enhances MSC survival and paracrine activity, but its effects in liver fibrosis remain unclear.
Wei‐Ting Kuo, Chen‐Yuan Hsiao, Sheng‐Hao Chiu, Shu‐Cheng Chou, Ching‐Shu Chiang, Jui‐Yu Chen, Solomon Chih‐Cheng Chen, Tien‐Hua Chen, Jia‐Fwu Shyu, Chi‐Hung Lin, Pei‐Jiun Tsai   +10 more
wiley   +1 more source